| Line 322: | Line 322: | ||
*Citation: D.V. Poltavski, T. Petros, Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits, Physiology & Behavior, Volume 87, Issue 3, 2006, Pages 614-624, ISSN 0031-9384, doi: 10.1016/j.physbeh.2005.12.011. | *Citation: D.V. Poltavski, T. Petros, Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits, Physiology & Behavior, Volume 87, Issue 3, 2006, Pages 614-624, ISSN 0031-9384, doi: 10.1016/j.physbeh.2005.12.011. | ||
*Keywords: ADHD, Transdermal nicotine, CPT, WCST, Stroop, Attention, Memory | *Keywords: ADHD, Transdermal nicotine, CPT, WCST, Stroop, Attention, Memory | ||
===1996 [https://pubmed.ncbi.nlm.nih.gov/8741955/ Nicotine effects on adults with attention-deficit/hyperactivity disorder]=== | |||
*Nicotine caused a significant overall nicotine-induced improvement on the CGI. This effect was significant when only the nonsmokers were considered, which indicated that it was not due merely to withdrawal relief. Nicotine caused significantly increased vigor as measured by the POMS test. Nicotine caused an overall significant reduction in reaction time (RT) on the CPT, as well as, with the smokers, a significant reduction in another index of inattention, variability in reaction time over trial blocks. Nicotine improved accuracy of time estimation and lowered variability of time-estimation response curves. Because improvements occurred among nonsmokers, the nicotine effect appears not to be merely a relief of withdrawal symptoms. It is concluded that nicotine deserves further clinical trials with ADHD. | |||
<br> | |||
==Mental Health - Anxiety== | ==Mental Health - Anxiety== | ||
edits